Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Se-Jin | - |
dc.contributor.author | Kim, Jungho | - |
dc.contributor.author | Kang, Seounghun | - |
dc.contributor.author | Cha, Hyung Jin | - |
dc.contributor.author | Shin, Hojeong | - |
dc.contributor.author | Park, Jisang | - |
dc.contributor.author | Jang, Yong-Suk | - |
dc.contributor.author | Woo, Jae-Sung | - |
dc.contributor.author | Won, Cheolhee | - |
dc.contributor.author | Min, Dal-Hee | - |
dc.date.accessioned | 2021-08-31T01:33:43Z | - |
dc.date.available | 2021-08-31T01:33:43Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2020-05 | - |
dc.identifier.issn | 2375-2548 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/56152 | - |
dc.description.abstract | Direct-acting agents against viral components are considered as the most promising candidates for the successful antiviral therapeutics. To date, no direct-acting drugs exist for the treatment against dengue virus (DV) infection, which can develop into life-threatening diseases. RNA-dependent RNA polymerase (RdRp), an RNA virus-specific enzyme highly conserved among various viral families, has been known as the broad-range antiviral drug target. Here, we developed an RNA-based graphene biosensor system [RNA nano-graphene oxide system (RANGO)] to enable the fluorescence-based quantitative analysis of the RdRp enzyme activity. We used the RANGO system to a high-throughput chemical screening to identify novel direct-acting antiviral drug candidates targeting DV RdRp from the FDA-approved small-molecule library. RANGO accelerated the massive selection of drug candidates. We found that one of the selected hit compounds, montelukast, showed antiviral activity in vitro and in vivo by directly inhibiting replication of DV and thus relieved related symptoms. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | AMER ASSOC ADVANCEMENT SCIENCE | - |
dc.subject | DENGUE VIRUS PATHOGENESIS | - |
dc.subject | DOUBLE-BLIND | - |
dc.subject | JAPANESE ENCEPHALITIS | - |
dc.subject | MOUSE MODEL | - |
dc.subject | MICE | - |
dc.subject | INHIBITOR | - |
dc.subject | CELLS | - |
dc.subject | ASSAY | - |
dc.subject | REPLICATION | - |
dc.subject | PLATFORM | - |
dc.title | Discovery of direct-acting antiviral agents with a graphene-based fluorescent nanosensor | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Woo, Jae-Sung | - |
dc.identifier.doi | 10.1126/sciadv.aaz8201 | - |
dc.identifier.scopusid | 2-s2.0-85086355998 | - |
dc.identifier.wosid | 000537238200027 | - |
dc.identifier.bibliographicCitation | SCIENCE ADVANCES, v.6, no.22 | - |
dc.relation.isPartOf | SCIENCE ADVANCES | - |
dc.citation.title | SCIENCE ADVANCES | - |
dc.citation.volume | 6 | - |
dc.citation.number | 22 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Science & Technology - Other Topics | - |
dc.relation.journalWebOfScienceCategory | Multidisciplinary Sciences | - |
dc.subject.keywordPlus | DENGUE VIRUS PATHOGENESIS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | JAPANESE ENCEPHALITIS | - |
dc.subject.keywordPlus | MOUSE MODEL | - |
dc.subject.keywordPlus | MICE | - |
dc.subject.keywordPlus | INHIBITOR | - |
dc.subject.keywordPlus | CELLS | - |
dc.subject.keywordPlus | ASSAY | - |
dc.subject.keywordPlus | REPLICATION | - |
dc.subject.keywordPlus | PLATFORM | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.